Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

MicroRNAs in Hepatobiliary and Pancreatic Cancers.

Saito Y, Suzuki H, Matsuura M, Sato A, Kasai Y, Yamada K, Saito H, Hibi T.

Front Genet. 2011 Sep 16;2:66. doi: 10.3389/fgene.2011.00066. eCollection 2011.

2.

The role of microRNAs in gastrointestinal cancers.

Saito Y, Suzuki H, Hibi T.

J Gastroenterol. 2009;44 Suppl 19:18-22. doi: 10.1007/s00535-008-2285-3. Epub 2009 Jan 16.

PMID:
19148788
3.

microRNAs as oncogenes and tumor suppressors.

Zhang B, Pan X, Cobb GP, Anderson TA.

Dev Biol. 2007 Feb 1;302(1):1-12. Epub 2006 Aug 16. Review.

4.

MicroRNAs in cancers and neurodegenerative disorders.

Saito Y, Saito H.

Front Genet. 2012 Sep 26;3:194. doi: 10.3389/fgene.2012.00194. eCollection 2012.

5.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
6.

The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.

Kinoshita T, Hanazawa T, Nohata N, Okamoto Y, Seki N.

J Hum Genet. 2012 Sep;57(9):556-63. doi: 10.1038/jhg.2012.75. Epub 2012 Jun 21. Review.

PMID:
22718022
7.

MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Wang C, Ren R, Hu H, Tan C, Han M, Wang X, Zheng Y.

Chin J Cancer Res. 2014 Feb;26(1):17-29. doi: 10.3978/j.issn.1000-9604.2014.01.01.

8.

MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.

Nohata N, Hanazawa T, Kinoshita T, Okamoto Y, Seki N.

Auris Nasus Larynx. 2013 Apr;40(2):143-9. doi: 10.1016/j.anl.2012.07.001. Epub 2012 Jul 24. Review.

PMID:
22831895
9.

MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.

Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L, Han S, Yuan Q, Yang M.

PLoS Genet. 2015 Dec 28;11(12):e1005726. doi: 10.1371/journal.pgen.1005726. eCollection 2015 Dec. Erratum in: PLoS Genet. 2016 Jan;12(1):e1005825.

10.

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.

Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X.

Oncotarget. 2015 Mar 30;6(9):6977-88.

11.

An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J, Li G.

BMC Med Genomics. 2012 Jan 19;5:3. doi: 10.1186/1755-8794-5-3.

12.

Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.

Tréhoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, Jonckheere N, Van Seuningen I.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2392-403. doi: 10.1016/j.bbamcr.2015.05.033. Epub 2015 May 31.

13.

Role of MicroRNAs in Hepatocellular Carcinoma.

Zhu Z, Zhang X, Wang G, Zheng H.

Hepat Mon. 2014 Aug 1;14(8):e18672. doi: 10.5812/hepatmon.18672. eCollection 2014 Aug. Review.

14.

miRNA and cancer; computational and experimental approaches.

Tutar Y.

Curr Pharm Biotechnol. 2014;15(5):429.

PMID:
25189575
15.

Epigenetic activation of tumor suppressor microRNAs in human cancer cells.

Saito Y, Jones PA.

Cell Cycle. 2006 Oct;5(19):2220-2. Epub 2006 Oct 1. Review.

PMID:
17012846
16.

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.

Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.

World J Surg. 2009 Apr;33(4):698-709. doi: 10.1007/s00268-008-9833-0. Review.

17.

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.

Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, Willenbring H, Dupuy A, Chen X, Brown D, Chang AN, Goga A.

Hepatology. 2014 Jan;59(1):202-15. doi: 10.1002/hep.26662. Epub 2013 Nov 22.

18.

MicroRNAs: small but potent oncogenes or tumor suppressors.

Lee YS, Dutta A.

Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Review.

PMID:
16784027
19.

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.

Carcinogenesis. 2010 May;31(5):766-76. doi: 10.1093/carcin/bgp250. Epub 2009 Oct 20.

PMID:
19843643
20.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

Supplemental Content

Support Center